Cargando…
Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized Mice
Excessive or inappropriate inflammatory responses can cause serious and even fatal diseases. The CCAAT/enhancer-binding protein alpha (CEBPA) gene encodes C/EBPα, a transcription factor that plays a fundamental role in controlling maturation of the myeloid lineage and is also expressed during the la...
Autores principales: | Zhou, Jiehua, Li, Haitang, Xia, Xin, Herrera, Alberto, Pollock, Nicolette, Reebye, Vikash, Sodergren, Mikael H., Dorman, Stephanie, Littman, Bruce H., Doogan, Declan, Huang, Kai-Wen, Habib, Robert, Blakey, David, Habib, Nagy A., Rossi, John J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520465/ https://www.ncbi.nlm.nih.gov/pubmed/30852139 http://dx.doi.org/10.1016/j.ymthe.2019.02.018 |
Ejemplares similares
-
MTL-CEBPA Combined with Immunotherapy or RFA Enhances Immunological Anti-Tumor Response in Preclinical Models
por: Huang, Kai-Wen, et al.
Publicado: (2021) -
Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma
por: Setten, Ryan L., et al.
Publicado: (2018) -
Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer
por: Voutila, Jon, et al.
Publicado: (2017) -
Gene activation of CEBPA using saRNA: Preclinical studies of the first in human saRNA drug candidate for liver cancer
por: Reebye, Vikash, et al.
Publicado: (2018) -
Cannabinoids in the landscape of cancer
por: Mangal, Nagina, et al.
Publicado: (2021)